Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition.
about
Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironmentNovel perspectives on therapeutic modulation of the gut microbiotaModeling-Enabled Systems Nutritional ImmunologyPrenatal methyl-donor supplementation augments colitis in young adult miceStriking a Balance with Help from our Little Friends - How the Gut Microbiota Contributes to Immune HomeostasisThe intestinal microbiota modulates the anticancer immune effects of cyclophosphamide.Dynamic microbe and molecule networks in a mouse model of colitis-associated colorectal cancer.Safety and efficacy of the immunosuppressive agent 6-tioguanine in murine model of acute and chronic colitis.Loss of sex and age driven differences in the gut microbiome characterize arthritis-susceptible 0401 mice but not arthritis-resistant 0402 miceThe microaerophilic microbiota of de-novo paediatric inflammatory bowel disease: the BISCUIT study.Characterization of adherent bacteroidales from intestinal biopsies of children and young adults with inflammatory bowel diseaseAlteration of intestinal microbiota in mice orally administered with salmon cartilage proteoglycan, a prophylactic agent.Effects of vendor and genetic background on the composition of the fecal microbiota of inbred miceHIV-induced alteration in gut microbiota: driving factors, consequences, and effects of antiretroviral therapy.Assessment of Fecal Microflora Changes in Pigs Supplemented with Herbal Residue and Prebiotic.Diet- and Genetically-Induced Obesity Differentially Affect the Fecal Microbiome and Metabolome in Apc1638N MiceIntestinal microbiota modulates gluten-induced immunopathology in humanized mice.The human milk oligosaccharide 2'-fucosyllactose augments the adaptive response to extensive intestinal.Pglyrp-Regulated Gut Microflora Prevotella falsenii, Parabacteroides distasonis and Bacteroides eggerthii Enhance and Alistipes finegoldii Attenuates Colitis in Mice.Intestinal microbiota could transfer host Gut characteristics from pigs to mice.Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity.Low dietary iron intake restrains the intestinal inflammatory response and pathology of enteric infection by food-borne bacterial pathogens.Further analysis reveals new gut microbiome markers of type 2 diabetes mellitus.Development of gut inflammation in mice colonized with mucosa-associated bacteria from patients with ulcerative colitisInflammation and colorectal cancer: colitis-associated neoplasia.Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice.Induced and natural regulatory T cells in the development of inflammatory bowel disease.Altered gut microbiota promotes colitis-associated cancer in IL-1 receptor-associated kinase M-deficient mice.Structural modulation of the gut microbiota and the relationship with body weight: compared evaluation of liraglutide and saxagliptin treatment.Triterpenoid herbal saponins enhance beneficial bacteria, decrease sulfate-reducing bacteria, modulate inflammatory intestinal microenvironment and exert cancer preventive effects in ApcMin/+ mice.Differential induction of antimicrobial REGIII by the intestinal microbiota and Bifidobacterium breve NCC2950.Sex differences in colonization of gut microbiota from a man with short-term vegetarian and inulin-supplemented diet in germ-free mice.Starter Feeding Supplementation Alters Colonic Mucosal Bacterial Communities and Modulates Mucosal Immune Homeostasis in Newborn Lambs.Microbiota network and mathematic microbe mutualism in colostrum and mature milk collected in two different geographic areas: Italy versus Burundi.Stressor exposure has prolonged effects on colonic microbial community structure in Citrobacter rodentium-challenged mice.The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.Microbes and microbial effector molecules in treatment of inflammatory disorders.Two faces of microbiota in inflammatory and autoimmune diseases: triggers and drugs.Are vaccination models suitable to determine whether probiotics have beneficial health effects in the general population?Disturbances of the Perioperative Microbiome Across Multiple Body Sites in Patients Undergoing Pancreaticoduodenectomy.
P2860
Q21562212-6870460A-58D5-42ED-9FC9-214F4A699010Q26745706-3163C548-23FE-41D5-BBA9-0A7D40084C8EQ26766623-7D4C4B51-A870-4A8B-8324-74B0070A14C5Q27308040-16196145-E051-4B75-A5FA-DB3F9F83A6CBQ28067700-E2218D2C-35A2-4E21-BEA6-D2B39723582DQ31144277-4AFAE508-E6B9-491E-BE87-23977ACBFFD6Q33613855-ED73696D-1DE3-4FC9-8E29-9B8661CC05E8Q33890504-DB4B69DE-BC8E-48EC-AEE2-F7922A454611Q34254430-4D7E5AC8-2228-4565-883D-16B1B8C8FCABQ34648376-C419700D-471F-4CBB-B5FE-36FB1CC9523CQ34775582-8B4A1FDF-C679-4276-B4FE-6BABC40B94CDQ34990474-75356303-2DE9-47E7-B4D8-3477EEF75D48Q35078945-D9CEBB8A-6051-45BD-890A-E62FF2C74521Q35216193-C6005FD2-AD35-4F42-AC5B-A783C0FB7331Q35692108-674BFA87-76C1-42F8-9422-E9192706F327Q35748788-4C2EC22C-C79B-4AC7-9F61-969118729041Q35803031-E1F67242-58BD-47C6-BEA8-CFAD1A858B50Q35878023-E62D2232-3042-4BAC-AB4B-540BF9540386Q35884186-1D46E7C9-183E-4561-ABBE-3D396FCB3225Q36160705-2D8ADA3D-1A44-410F-90D0-5CDD3215CDB0Q36182975-C72643C7-E79A-47DD-84F2-2570F8DA4958Q36202128-11C04D12-CD75-40E4-9BD2-D8FC8F39740EQ36220418-8FA25F27-9814-4F4E-BFC3-F7F4847E1F19Q36393719-CA71FF3C-026A-43B8-A587-4A518BE739ABQ36597803-40443DCA-7D68-4D2D-883E-99888C36C390Q36658938-5072942D-5128-49AB-B719-04A0DC5067D1Q36948341-2B355768-D09E-4755-8ADD-ACA08ECFFA5CQ37097054-93B739EE-0A41-4C87-A4A4-66CA65BA9651Q37260757-A1B2D583-5320-4025-A7BC-01BD779ED10BQ37327715-FA1F4141-90EA-44AF-956A-8FE6631973AFQ37335567-6CCA1589-1B85-4788-886A-2856E7C9C69CQ37379455-0D5C0579-0264-442F-AE75-4E8005D6621DQ37715459-009688D3-9411-4376-8154-C19F8B4073FEQ37719251-8A50A866-0AC2-42B4-A092-24CCCF5F4E0EQ37721486-6DA00ED4-0739-4611-8D8A-9769EA61CFA1Q37729525-20B9DCB7-78FA-4C6F-8E49-8628DF0294D4Q37968291-846011C2-D77A-4C7A-91F0-42F6EC3BECC4Q38055197-15E4CF46-039E-45FE-8399-4E8554FDE3E1Q38071912-AB56C5D1-D033-4F32-BA58-393ACC74D1CDQ38795216-4BA439A7-C450-4E48-950A-57F738EC5CAE
P2860
Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Oral administration of Parabac ...... ty and microbiota composition.
@en
Oral administration of Parabac ...... ty and microbiota composition.
@nl
type
label
Oral administration of Parabac ...... ty and microbiota composition.
@en
Oral administration of Parabac ...... ty and microbiota composition.
@nl
prefLabel
Oral administration of Parabac ...... ty and microbiota composition.
@en
Oral administration of Parabac ...... ty and microbiota composition.
@nl
P2093
P2860
P1476
Oral administration of Parabac ...... ty and microbiota composition.
@en
P2093
H Tlaskalova-Hogenova
K Klimesova
P Rossmann
T Hudcovic
P2860
P304
P356
10.1111/J.1365-2249.2010.04286.X
P577
2010-11-19T00:00:00Z